The new era of nanotechnology, an alternative to change cancer treatment A Jurj, C Braicu, LA Pop, C Tomuleasa, CD Gherman, I Berindan-Neagoe Drug design, development and therapy, 2871-2890, 2017 | 173 | 2017 |
Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ... J Gastrointestin Liver Dis 24 (4), 435-443, 2015 | 99 | 2015 |
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression D Gulei, L Magdo, A Jurj, L Raduly, R Cojocneanu-Petric, A Moldovan, ... Cell Death & Disease 9 (2), 66, 2018 | 87 | 2018 |
How to diagnose and treat a cancer of unknown primary site. C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ... Journal of Gastrointestinal & Liver Diseases 26 (1), 2017 | 75 | 2017 |
The epigenetics of triple-negative and basal-like breast cancer: current knowledge DC Temian, LA Pop, AI Irimie, I Berindan-Neagoe Journal of breast cancer 21 (3), 233, 2018 | 72 | 2018 |
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples OL Braicu, L Budisan, R Buiga, A Jurj, P Achimas-Cadariu, LA Pop, ... OncoTargets and therapy, 4225-4238, 2017 | 56 | 2017 |
Inhibitory effect of CAPE and kaempferol in colon cancer cell lines—possible implications in new therapeutic strategies L Budisan, D Gulei, A Jurj, C Braicu, O Zanoaga, R Cojocneanu, L Pop, ... International journal of molecular sciences 20 (5), 1199, 2019 | 54 | 2019 |
Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure O Balacescu, L Balacescu, O Tudoran, N Todor, M Rus, R Buiga, ... BMC cancer 14, 1-14, 2014 | 52 | 2014 |
Aberrant miRNAs expressed in HER-2 negative breast cancers patient C Braicu, L Raduly, G Morar-Bolba, R Cojocneanu, A Jurj, LA Pop, ... Journal of Experimental & Clinical Cancer Research 37, 1-16, 2018 | 51 | 2018 |
Chimeric antigen receptor T-cells for the treatment of B-cell acute lymphoblastic leukemia C Tomuleasa, S Fuji, C Berce, A Onaciu, S Chira, B Petrushev, WT Micu, ... Frontiers in Immunology 9, 239, 2018 | 51 | 2018 |
Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression C Braicu, R Buiga, R Cojocneanu, M Buse, L Raduly, LA Pop, S Chira, ... Journal of Experimental & Clinical Cancer Research 38, 1-17, 2019 | 42 | 2019 |
Next generation sequencing technology in lung cancer diagnosis C Cainap, O Balacescu, SS Cainap, LA Pop Biology 10 (9), 864, 2021 | 37 | 2021 |
Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model C Braicu, V Pileczki, L Pop, RC Petric, S Chira, E Pointiere, ... PLoS One 10 (4), e0120936, 2015 | 33 | 2015 |
Early diagnosis and screening in lung cancer C Cainap, LA Pop, O Balacescu, SS Cainap American Journal of Cancer Research 10 (7), 1993, 2020 | 31 | 2020 |
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ... Critical Reviews in Clinical Laboratory Sciences 55 (7), 501-515, 2018 | 31 | 2018 |
Genetic alterations in sporadic triple negative breast cancer LA Pop, RM Cojocneanu-Petric, V Pileczki, G Morar-Bolba, A Irimie, ... The Breast 38, 30-38, 2018 | 28 | 2018 |
TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expression levels: a pilot study C Ionescu, C Braicu, R Chiorean, R Cojocneanu Petric, E Neagoe, L Pop, ... J Gastrointestin Liver Dis 23 (4), 413-418, 2014 | 28 | 2014 |
New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells CA Ciocan-Cartita, A Jurj, O Zanoaga, R Cojocneanu, LA Pop, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 23 | 2020 |
New insights in gene expression alteration as effect of paclitaxel drug resistance in triple negative breast cancer cells A Jurj, LA Pop, O Zanoaga, CA Ciocan-Cârtiță, R Cojocneanu, ... Cell. Physiol. Biochem 54 (4), 648-664, 2020 | 23 | 2020 |
Approach to the adult acute lymphoblastic leukemia patient V Sas, V Moisoiu, P Teodorescu, S Tranca, L Pop, S Iluta, S Pasca, ... Journal of Clinical Medicine 8 (8), 1175, 2019 | 22 | 2019 |